Medicago Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Medicago Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014327
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Medicago Inc (Medicago), a subsidiary of Mitsubishi Tanabe Pharma Corp is a biopharmaceutical company that develops and produces vaccines and antibodies. The company concentrates on the discovery and development of novel vaccines and therapeutic proteins for infectious diseases. Its pipeline products includes pandemic flu vaccine and seasonal flu vaccines. Medicago’s seasonal flu vaccine is used for contagious respiratory illness. The company also develops H1N1 pandemic candidate vaccines; and rabies, rotavirus and biosimilar vaccination. It uses its technologies including plant-based proficia technology, virus-like particles and the VLPExpress platform for the development of vaccines. The company conducts research activities in the areas of biodefence and biosimilar therapies. It operates in North Carolina, and production facility in Canada. Medicago is headquartered in Quebec, Canada.

Medicago Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Medicago Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Medicago Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Medicago Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Medicago Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Medicago Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Medicago Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Medicago Enters into Contract with Public Health Agency of Canada 10
Medicago Enters into Agreement with University of Cape Town 11
Medicago Enters Into Co-Development Agreement With A Global Pharma Company 12
Medicago Enters Into Co-Development Agreement With Mitsubishi Tanabe Pharma For Vaccines 13
Medicago Enters Into Co-Development Agreement With Cellectis 14
Medicago Enters Into Research Collaboration With USAMRIID 15
Licensing Agreements 16
Immune Design And Medicago Enter Into Licensing Agreement To Develop Influenza Vaccines 16
Medicago Enters Into Licensing Agreement With Philip Morris Products For Influenza Vaccines 17
Philip Morris Products Enters Into Licensing Agreement With Medicago For Protein Development Technologies 18
Equity Offering 19
Medicago Announces Private Placement Of Common Stock For US$3.4 Million 19
Medicago Completes Second Tranche Of Private Placement Of Shares For US$11 Million 20
Medicago Completes Private Placement Of Common Stock For US$24.5 Million 21
Medicago Completes Public Offering Of Units For US$17.72 Million 22
Acquisition 24
Medicago Completes Divestment Of 53.9% Stake To Mitsubishi Tanabe Pharma For US$ 172 Million In Going Private Transaction 24
Medicago Inc – Key Competitors 26
Medicago Inc – Key Employees 27
Medicago Inc – Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Recent Developments 29
Clinical Trials 29
Sep 27, 2017: Mitsubishi Tanabe Pharma: Notice of the Start of Phase 3 Clinical Study of VLP Seasonal Influenza Vaccine 29
Sep 26, 2017: Medicago Announces Phase 3 Study of VLP Quadrivalent Influenza Vaccine 30
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31

List of Tables
Medicago Inc, Pharmaceuticals & Healthcare, Key Facts 2
Medicago Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Medicago Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Medicago Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Medicago Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Medicago Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Medicago Enters into Contract with Public Health Agency of Canada 10
Medicago Enters into Agreement with University of Cape Town 11
Medicago Enters Into Co-Development Agreement With A Global Pharma Company 12
Medicago Enters Into Co-Development Agreement With Mitsubishi Tanabe Pharma For Vaccines 13
Medicago Enters Into Co-Development Agreement With Cellectis 14
Medicago Enters Into Research Collaboration With USAMRIID 15
Immune Design And Medicago Enter Into Licensing Agreement To Develop Influenza Vaccines 16
Medicago Enters Into Licensing Agreement With Philip Morris Products For Influenza Vaccines 17
Philip Morris Products Enters Into Licensing Agreement With Medicago For Protein Development Technologies 18
Medicago Announces Private Placement Of Common Stock For US$3.4 Million 19
Medicago Completes Second Tranche Of Private Placement Of Shares For US$11 Million 20
Medicago Completes Private Placement Of Common Stock For US$24.5 Million 21
Medicago Completes Public Offering Of Units For US$17.72 Million 22
Medicago Completes Divestment Of 53.9% Stake To Mitsubishi Tanabe Pharma For US$ 172 Million In Going Private Transaction 24
Medicago Inc, Key Competitors 26
Medicago Inc, Key Employees 27
Medicago Inc, Other Locations 28
Medicago Inc, Subsidiaries 28

★海外企業調査レポート[Medicago Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Fortis Healthcare Ltd (FORTIS):企業の財務・戦略的SWOT分析
    Fortis Healthcare Ltd (FORTIS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Coal India Ltd:企業のM&A・事業提携・投資動向
    Coal India Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Coal India Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Saskatchewan Telecommunications Holding Corporation:企業の戦略的SWOT分析
    Saskatchewan Telecommunications Holding Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key compe …
  • Afianzadora Latinoamericana Cia de Seguros S.A.:企業の戦略・SWOT・財務情報
    Afianzadora Latinoamericana Cia de Seguros S.A. - Strategy, SWOT and Corporate Finance Report Summary Afianzadora Latinoamericana Cia de Seguros S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, o …
  • Nattopharma ASA (NATTO):企業の財務・戦略的SWOT分析
    Summary Nattopharma ASA (Nattopharma) is a pharmaceutical company that develops and sells vitamin K2 for health care industries. The company's MenaQ7, a vitamin K2 as menaquinone-7 for bone and cardiovascular health and children’s health. Its MenaQ7 varieties are suitable for vegans and vegetarians, …
  • Seylan Bank Plc:企業の戦略・SWOT・財務分析
    Seylan Bank Plc - Strategy, SWOT and Corporate Finance Report Summary Seylan Bank Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • GN Hearing AS-医療機器分野:企業M&A・提携分析
    Summary GN Hearing A/S (GN Hearing) formerly, GN ReSound A/S, a subsidiary of GN Store Nord A/S is a medical equipment company that provides advanced hearing health care solutions. It manufactures advanced technology hearing instruments and solutions for all types of ear-related problems. The compan …
  • VSE Corporation (VSEC):企業の財務・戦略的SWOT分析
    VSE Corporation (VSEC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Cell Medica Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Cell Medica Ltd (Cell Medica), formerly Immunocode Ltd manufactures and commercializes cellular products. The company uses various technology platforms such as chimeric antigen receptor (CAR), Dominant T cell receptor (TCR), PENTRA Antibody technology and NKT cell platform for manufacturing …
  • MTR Corporation Ltd:戦略・SWOT・企業財務分析
    MTR Corporation Ltd - Strategy, SWOT and Corporate Finance Report Summary MTR Corporation Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Air Liquide Welding France, S.A.:企業の戦略・SWOT・財務情報
    Air Liquide Welding France, S.A. - Strategy, SWOT and Corporate Finance Report Summary Air Liquide Welding France, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Twenty-First Century Fox Inc. (FOXA):企業の財務・戦略的SWOT分析
    Twenty-First Century Fox Inc. (FOXA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Heineken Malaysia Berhad:企業の戦略・SWOT・財務情報
    Heineken Malaysia Berhad - Strategy, SWOT and Corporate Finance Report Summary Heineken Malaysia Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Koninklijke Ten Cate NV:企業の戦略的SWOT分析
    Koninklijke Ten Cate NV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Cti Engineering Co Ltd
    Cti Engineering Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Cti Engineering Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Oil Search Ltd Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Oil Search Ltd Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Oil Search Ltd (Oil Search) is an independent upstream energy company. It explores for, develops and produces oil, natural gas and natural gas liquids (NGL). The company has majority of its oil and ga …
  • Arab Bank (Switzerland) Ltd.:企業の戦略・SWOT・財務情報
    Arab Bank (Switzerland) Ltd. - Strategy, SWOT and Corporate Finance Report Summary Arab Bank (Switzerland) Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Raya Holding (RAYA):企業の財務・戦略的SWOT分析
    Raya Holding (RAYA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Novozymes AS (NZYM B):企業の財務・戦略的SWOT分析
    Novozymes AS (NZYM B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • TimberWest Forest Corporation:企業の戦略・SWOT・財務情報
    TimberWest Forest Corporation - Strategy, SWOT and Corporate Finance Report Summary TimberWest Forest Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆